BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28963304)

  • 1. Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study.
    Dorward J; Garrett N; Quame-Amaglo J; Samsunder N; Ngobese H; Ngomane N; Moodley P; Mlisana K; Schaafsma T; Donnell D; Barnabas R; Naidoo K; Abdool Karim S; Celum C; Drain PK
    BMJ Open; 2017 Sep; 7(9):e017507. PubMed ID: 28963304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
    Bardon AR; Dorward J; Sookrajh Y; Sayed F; Quame-Amaglo J; Pillay C; Feutz E; Ngobese H; Simoni JM; Sharma M; Cressey TR; Gandhi M; Lessells R; Moodley P; Naicker N; Naidoo K; Thomas K; Celum C; Abdool Karim S; Garrett N; Drain PK
    BMJ Open; 2021 Oct; 11(10):e050116. PubMed ID: 34610939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
    Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
    BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
    Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK
    Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
    Drain PK; Dorward J; Violette LR; Quame-Amaglo J; Thomas KK; Samsunder N; Ngobese H; Mlisana K; Moodley P; Donnell D; Barnabas RV; Naidoo K; Abdool Karim SS; Celum C; Garrett N
    Lancet HIV; 2020 Apr; 7(4):e229-e237. PubMed ID: 32105625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect.
    Reif LK; Belizaire ME; Seo G; Rouzier V; Severe P; Joseph JM; Joseph B; Apollon S; Abrams EJ; Arpadi SM; Elul B; Pape JW; McNairy ML; Fitzgerald DW; Kuhn L
    BMJ Open; 2020 Aug; 10(8):e036147. PubMed ID: 32868354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study.
    Dorward J; Sookrajh Y; Ngobese H; Lessells R; Sayed F; Bulo E; Moodley P; Samsunder N; Lewis L; Tonkin-Crine S; Drain PK; Hayward G; Butler CC; Garrett N
    BMJ Open; 2021 Feb; 11(2):e045373. PubMed ID: 33593788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection.
    Paton NI; Stöhr W; Oddershede L; Arenas-Pinto A; Walker S; Sculpher M; Dunn DT
    Health Technol Assess; 2016 Mar; 20(21):1-158. PubMed ID: 26986803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
    Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
    Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial.
    Barnabas RV; Szpiro AA; van Rooyen H; Asiimwe S; Pillay D; Ware NC; Schaafsma TT; Krows ML; van Heerden A; Joseph P; Shahmanesh M; Wyatt MA; Sausi K; Turyamureeba B; Sithole N; Morrison S; Shapiro AE; Roberts DA; Thomas KK; Koole O; Bershteyn A; Ehrenkranz P; Baeten JM; Celum C;
    Lancet Glob Health; 2020 Oct; 8(10):e1305-e1315. PubMed ID: 32971053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
    Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
    Trials; 2013 Jul; 14():230. PubMed ID: 23880306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation.
    Rosen S; Fox MP; Larson BA; Brennan AT; Maskew M; Tsikhutsu I; Bii M; Ehrenkranz PD; Venter WF
    BMJ Open; 2017 May; 7(5):e016340. PubMed ID: 28554939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    Hyle EP; Jani IV; Rosettie KL; Wood R; Osher B; Resch S; Pei PP; Maggiore P; Freedberg KA; Peter T; Parker RA; Walensky RP
    AIDS; 2017 Sep; 31(15):2135-2145. PubMed ID: 28906279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial.
    Meloni ST; Agbaji O; Chang CA; Agaba P; Imade G; Oguche S; Mukhtar A; Mitruka K; Cox MH; Zee A; Kanki P
    BMC Infect Dis; 2019 May; 19(1):368. PubMed ID: 31046695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
    Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
    AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
    Simeon K; Sharma M; Dorward J; Naidoo J; Dlamini N; Moodley P; Samsunder N; Barnabas RV; Garrett N; Drain PK
    PLoS One; 2019; 14(10):e0223669. PubMed ID: 31618220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.
    Qian SRW; Hassan SA; Scallon AJ; Oyaro P; Brown E; Wagude J; Mukui I; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Yongo N; Karauki E; Gao J; Otieno L; John-Stewart GC; Abuogi LL; Patel RC
    BMC Health Serv Res; 2022 Dec; 22(1):1540. PubMed ID: 36528677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study.
    Limbada M; Bwalya C; Macleod D; Floyd S; Schaap A; Situmbeko V; Hayes R; Fidler S; Ayles H;
    Trials; 2021 Jan; 22(1):52. PubMed ID: 33430928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.
    Fairlie L; Sawry S; Pals S; Sherman G; Williamson D; Le Roux J; Ngeno B; Berrie L; Diallo K; Cox MH; Mogashoa M; Chersich M; Modi S;
    J Acquir Immune Defic Syndr; 2023 Dec; 94(5):412-420. PubMed ID: 37949444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.